Cited by 185Diabetes, Cardiovascular Risks, and LipoproteinsCardiac Imaging and DiagnosticsHIV-related health complications and treatments

Measures of Insulin Resistance Add Incremental Value to the Clinical Diagnosis of Metabolic Syndrome in Association With Coronary Atherosclerosis

Reilly, Muredach P., Wolfe, Megan L., Rhodes, Thomas, Girman, Cynthia, Mehta, Nehal, Rader, Daniel J.·2004·Circulation

Abstract

Background— Whether measures of insulin resistance provide incremental information regarding atherosclerotic cardiovascular disease beyond current National Cholesterol Education Program (NCEP) Adult Treatment Panel III metabolic syndrome (MetSyn) criteria or inflammatory markers is uncertain. Methods and Results— We examined the association of insulin resistance and MetSyn with coronary artery calcification (CAC) in 840 asymptomatic nondiabetic subjects. Both NCEP and World Health Organization–defined MetSyn were associated (ordinal regression odds ratio [OR] and 95% confidence intervals for NCEP-defined MetSyn) with CAC after controlling for age, non-MetSyn risk factors, and plasma CRP levels (OR, 1.93 [1.43 to 2.60], P <0.001) and after further controlling for homeostasis model assessment index (HOMA) (OR, 1.56 [1.14 to 2.15], P =0.006). Conversely, HOMA was significantly associated with CAC after adjusting for age, non-MetSyn risk factors, and CRP levels (OR, 1.62 [1.31 to 2.01], P <0.001) and after further adjusting for NCEP-defined MetSyn (OR, 1.45 [1.16 to 1.82], P =0.007). Addition of HOMA to the NCEP MetSyn significantly improved the association with CAC, but addition of CRP data to MetSyn or HOMA did not. Conclusions— Both MetSyn and HOMA index were associated with coronary atherosclerosis independent of established risk factors, including CRP. These findings support the use of biomarkers of insulin resistance in addition to NCEP MetSyn criteria in assessing cardiovascular disease risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000138740.84883.9c

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Reilly, M. P., Wolfe, M. L., Rhodes, T., Girman, C., Mehta, N., & Rader, D. J.
Affiliations
University of Pennsylvania (US)
Venue
Circulation
Published
2004-08-17
Volume
110
Issue
7
Pages
803-809
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2104595366
Cited by
185
References
37
Citations by year
2025: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 2 · 2017: 9 · 2016: 7 · 2015: 1 · 2014: 10 · 2013: 10 · 2012: 15
FWCI
12.40
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Burroughs Wellcome Fund
  • University of Pennsylvania
  • Deutsches Krebsforschungszentrum
  • National Institutes of Health (RR00040, DK 19525)
  • National Heart, Lung, and Blood Institute (R01HL073278, R01 HL-73278-01)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 19525, P30DK019525)
  • National Center for Research Resources (K23RR015532, M01-RR-00040, M01RR000040, RR15532-02)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
Keywords
insulin resistance, metabolic syndrome, coronary artery calcification, coronary artery disease, HOMA, C-reactive protein, cardiovascular risk assessment, NCEP ATP III criteria, biomarkers
MeSH terms
Adult, Aged, Anthropometry, Blood Glucose, C-Reactive Protein, Calcinosis, Coronary Artery Disease, Cross-Sectional Studies, Female, Homeostasis, Humans, Hypertension, Inflammation, Insulin, Insulin Resistance, Lipids, Male, Middle Aged, Models, Biological, Obesity, Risk Factors, Hypertriglyceridemia, Biomarkers, Prevalence, Likelihood Functions, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review